Reading time is <1 mins
.
.
DOES THE IMPLANT CAUSE CANCER OF THE JAWBONE?
Intraoral malignant tumors, which are usually seen in men over the age of 60, have also recently begun to appear in women and young people under the age of 40.
Between 3 – 5 percent of all malignant tumors are located in the head and neck area. About half of them are located in the oral cavity, and intraoral cancer cells make up about 90 percent of the total. Tumors that are usually found in men over the age of 60 who have a habit of using tobacco and alcohol are defined as bad tumors. But this trend has begun to change, and it is increasingly observed in patients under the age of 40, women without any risk factors, adolescents, even children. At the same time, they have also been associated with other less typical risk factors: nutritional deficiencies, too high radiation exposure, irritating factors of dental or implant origin.
.
EDEMA MAY OCCUR
Dental implants have become one of the best options for treating patients without teeth in terms of oral rehabilitation and are considered the only form of treatment for some patients. Due to the universal use of dental implants, there are reports of an increase in the number of confusion in the literature regarding their use. Among the most common such complications are inflammatory processes affecting bone and soft tissues, known as periimplantitis. Decubitus is the most common form of decubitus. These conditions are often clinically edema, redness, increase the volume of tissue cells, and even that occurs with soft tissue injuries, and sometimes that requires a differential diagnosis of malignant changes in these views.
.
THE NUMBER OF CASES IS SMALL
To date, very few cases have been published on intraoral cancer cells with dental implants. There are even fewer publications on the primary malignant cancer cell in patients with a history of malignant disease at the local or regional level. But with the increase in the number of implant construction, it is expected that we will see an increase in cases of intraoral cancer cells.
Turkey Medicals – we will present an assessment of cases published in the literature on implant-associated oral cancers.
The mechanism by which dental implants can contribute to the development of intraoral cancer cells is very controversial. It argues that implant placement can contribute to the development of intraoral cancer cells from the epithelium to the spongy bone due to the loss of gingival ligaments.
.
IT PLAYS A ROLE IN THE DEVELOPMENT OF CANCER
The gum connection in the implant is constantly experiencing inflammation, which can affect the tissue balance and, accordingly, play an important role in the development of cancer: simple proteins, the factor that ensures the destruction of cancerous cells. Additional risk factors may also be october, such as uncomfortable factors such as improperly installed dentures or poor oral hygiene, alcohol and tobacco consumption. In the literature reviewed, the vast majority of the cases mentioned consisted of patients who had a history of cancer in other parts of the body prior to intraoral cancer cell or implant placement. Nutritional deficiencies can explain the rapid evolution of tissue disorder, given that gastric plastic significantly reduces the absorption of certain nutrients and vitamins at the gastric level, increases the rate of gastric and intestinal transit, and also reduces the absorption of certain essential elements. Each of them is associated with the factor of local irritation of the implants and can explain the process in a patient who does not have any toxic habits.
.
TISSUES DETERIORATE
Among the 18 cases in the studies conducted, only ten of the patients did not show malignant cancer or a history of cancer in 2004, he presented two cases of an intraoral cancer cell in a 64-year-old female patient and a 67-year-old male patient with no history of malignant tissue disorders or risk factors. In both cases, it turned out that the apparent tissue disorder was compatible with those associated with inflammatory processes affecting bone and soft tissues. in 2008, they reported a case of a 76 year-old man with a tissue disorder in his lower left region, associated with implants supporting a fixed prosthesis placed five years earlier.
The patient had no history of cancer, an inflammatory condition affecting bone and soft tissues, or inflammation of the tissue, or any known risk factors. in 2010, he presented a case of a 64 year old woman without a history of cancer, whose risk factors were moderate alcohol consumption and smoking in the past, presenting with an inflammation around the implants placed in the lower incisor region. In the study of tissues under the light microscope; in addition to safety limits, a moderately differentiated cancer cell was detected on the same side of the body that required surgical intervention by surgically removing the lymph node. in 2008, he presented the case of a 76-year-old man who had two implants in the lower right jaw about five years earlier, then developed an outward-growing tissue disorder, had a history of high blood pressure and high uric acid levels in his blood. The patient did not present risk factors and was regularly seen for check-ups.
.
As an initial treatment, the inflammations affecting the bone and soft tissues were cleared and a biopsy was performed 15 days later. An examination with a light microscope revealed a well-differentiated cancer cell. Then the cancer cell was cut out and removed.
.
IT NEEDS TO BE REMOVED COMFORTABLY
The most common cancer cell associated with dental implants is peri-implantitis (inflammation that affects bone and soft tissues). That is why it is necessary to thoroughly monitor any of these symptoms in order to carry out the final cancer cell screening.
Therefore, we believe that from a medical point of view, it should be possible to remove any implant installed on a prosthesis relatively conveniently for the purpose of examining the gingival-implant tissues and monitoring possible changes in this area.
.
REGULAR CHECK-UPS ARE MANDATORY FOR AT-RISK PATIENTS
Before an Antalya implant treatment, the patient’s risk factors must be structured, and an appropriate cost-benefit assessment must be performed for each patient.
In dental patients with risk factors, regular check-ups should be carried out. A complete examination of the oral cavity should be performed. A biopsy should be performed to establish the correct diagnosis of a lesion as soon as possible in case of any problems, and then an examination of the tissues under a light microscope to diagnose the disease.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.